Log In
Print this Print this

PFKFB3 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Kancera AB
DescriptionPFKFB3 inhibitor
Molecular Target 6-phosphofructo-2-kinase fructose-2,6-biphosphatase 3 (PFKFB3)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerSprint Bioscience AB

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today